![]() |
市場調查報告書
商品編碼
1402029
代孕市場至2030年的預測:按類型、年齡層、技術、最終用戶和地區分類的全球分析Surrogacy Market Forecasts to 2030 - Global Analysis By Type, Age Group, Technology, End User and by Geography |
根據Stratistics MRC的資料,2023年全球代孕市場規模為2.1034億美元,預計到2030年將達到3.6282億美元,預測期內年複合成長率為8.1%。
在稱為代孕的生殖醫學中,代理孕母代替別人或一對夫婦生孩子。當由於健康狀況而難以或不可能正常懷孕時,可以使用這種輔助生殖技術。代孕主要有兩種型態:妊娠代孕,即代孕母親透過體外受精(IVF)以受精的胚胎代孕;傳統代孕,即代孕母親提供卵子。
根據世界衛生組織(WHO)的報告,開發中國家有四分之一的夫婦患有不孕症。此外,全世界每年有 6,000 至 8,000 萬對夫婦遭受不孕不育的困擾,光是印度就有 1,500 至 2,000 萬對夫婦(25%)遭受不孕的困擾。
意識提升和接受度
社會對不孕症問題的認知提高和公開對話已導致代孕被視為合法且富有同情心的生殖選擇。此外,倡導團體、網路論壇和教育計畫幫助消除圍繞代孕的汙名,並為與不孕症抗爭的單身和夫婦創造更鼓勵性的氛圍。
代理人的數量是有限的。
由於缺乏願意且合適的代孕媽媽,代孕市場受到嚴重限制。難以找到符合醫療和心理要求的合適候選人可能會延遲匹配有意願的父母和代孕媽媽的過程。此外,社會汙名、對潛在健康風險的擔憂以及代孕程序的嚴格性也可能導致這種短缺。
生殖醫學的技術進步
由於生殖醫學技術的不斷進步,包括基因檢測、胚胎篩檢和人工生殖技術的進步,代孕市場存在著巨大的機會。此外,成功率的提高,胚胎選擇的改進以及更先進的生育治療的開發使得代孕成為尋求代孕的父母更可行且更具成本效益的選擇。
監管變化和法律不確定性
不同司法管轄區關於代孕的不同法律體制為代孕產業帶來了嚴重風險。此外,法律的快速變化和法律的模糊性給代孕組織、有意為人父母者和代孕媽媽帶來了困難,並可能導致法律衝突和併發症,阻礙代孕協議的有序進展。
COVID-19大流行對代孕市場產生了重大影響,為輔助生殖技術領域帶來了困難和破壞。大流行帶來的旅行限制和關閉阻礙了參與代孕過程的意向父母、代孕媽媽和醫療保健提供者的國際流動。持續的健康問題、診所關閉和生育治療的延誤導致代孕手術暫時減少。此外,大流行的經濟影響可能會影響父母接受代孕服務的能力。
妊娠代孕產業預計將在預測期內成為最大的產業
作為輔助生殖技術中最常見和首選的方法,妊娠代孕佔據了最大的市場佔有率。在懷孕代孕中,卵子和精子由捐贈者或預期父母提供,胚胎是透過體外受精(IVF)產生的。這種方法透過切斷代孕媽媽和孩子之間的遺傳聯繫,提供了更多的情感和法律清晰度。此外,生殖技術的進步使妊娠代孕廣泛認為是一個更可控和可預測的過程。
預計不孕症診所領域在預測期內將出現最高的年複合成長率。
在代孕市場中,年複合成長率最高的細分市場是生育診所。這些專業診所提供最先進的生殖服務,對於解決日益增加的不孕症發病率非常重要。生育診所提供全面的診斷評估,最先進的輔助生殖技術(ART)(包括體外受精(IVF))以及根據每位患者和夫婦的需求量身定做的個人化治療方案。此外,社會對輔助生殖技術的接受度不斷提高,人們對不孕症問題的認知不斷提高,對生育診所提供的服務的需求也隨之增加。
北美佔據全球代孕市場的最大佔有率。該地區(包括美國和加拿大)由於先進的醫療保健系統、高意識和對生殖技術的大量投資而佔據主導地位。不孕症服務的高需求部分是由於文化上對輔助生殖技術(ART)的接受度以及不孕問題的普遍存在。此外,由於主要生育診所、研究機構和技術開發的集中,北美作為生殖醫療產業主要參與者的地位進一步得到加強。
在全球代孕市場中,亞太地區的年複合成長率最高。不孕症盛行率上升以及人們對輔助生殖技術(ART)的理解和接受程度不斷提高,推動了亞太地區對生殖健康服務的需求。該地區的快速成長歸因於多種因素,包括生活方式的演變、計劃生育的延遲以及生殖健康的改善。此外,亞太國家不孕症治療的擴大和醫療基礎設施的改善支持市場成長。
According to Stratistics MRC, the Global Surrogacy Market is accounted for $210.34 million in 2023 and is expected to reach $362.82 million by 2030 growing at a CAGR of 8.1% during the forecast period. A surrogate woman bears and gives birth to a child on behalf of another person or couple in a reproductive arrangement known as surrogacy. When conventional conception is difficult or impossible due to medical conditions, this assisted reproductive technology is used. Moreover, the two main forms of surrogacy are gestational surrogacy, in which the surrogate carries an embryo fertilized by in vitro fertilization (IVF), usually using the genetic material of the intended parents or donors, and traditional surrogacy, in which the surrogate contributes her egg.
According to a report by the World Health Organization (WHO), one in four couples in developing nation's experiences infertility. Additionally, 60-80 million couples worldwide suffer from infertility each year, with 15-20 million (25%) residing in India alone.
Raising awareness and acceptance
Growing awareness campaigns and a more candid conversation about fertility issues in society are supporting surrogacy's growing acceptance as a legal and compassionate reproductive option. Additionally, advocacy groups, internet forums, and educational programs help dispel the stigmas surrounding surrogacy and create a more encouraging atmosphere for single people and couples dealing with infertility.
Limited number of surrogates available
The surrogacy market is significantly constrained by the lack of willing and suitable surrogates. The process of matching intended parents with surrogates can be delayed when appropriate candidates who fulfill both medical and psychological requirements are difficult to find. Furthermore, social stigmas, worries about potential health hazards, or the rigorous requirements of the surrogacy procedure could all contribute to this shortage.
Technological progress in reproductive health
Significant opportunities exist for the surrogacy market as a result of ongoing technological advancements in reproductive medicine, such as advances in genetic testing, embryo screening, and artificial reproductive techniques. Moreover, for intended parents, surrogacy is becoming a more practical and cost-effective option thanks to increased success rates, improved embryo selection, and the development of more advanced fertility treatments.
Regulation changes and legal uncertainties
Diverse legal frameworks for surrogacy across different jurisdictions present a serious risk to the surrogacy industry. Additionally, swift alterations in laws or legal ambiguities could pose difficulties for surrogacy organizations, intended parents, and surrogates, resulting in possible legal conflicts and complications that could hinder the orderly advancement of surrogacy agreements.
The COVID-19 pandemic has had a major effect on the surrogacy market and brought difficulties and disturbances to the assisted reproductive sector. Travel restrictions and lockdowns brought on by the pandemic have hindered the international mobility of intended parents, surrogates, and healthcare providers participating in the surrogacy process. There has been a brief decrease in surrogacy procedures due to ongoing health concerns, clinic closures, and delays in fertility treatments. Furthermore, the pandemic's effects on the economy could have an impact on intended parents' ability to afford surrogacy services.
The Gestational Surrogacy segment is expected to be the largest during the forecast period
As the most common and favored method of assisted reproduction, gestational surrogacy commands the largest share of the market. When a person is used in a gestational surrogacy, their eggs and sperm from donors or the intended parents are used to create an embryo through in vitro fertilization (IVF). This approach provides more emotional and legal clarity by severing genetic ties between the surrogate and the child. Moreover, reproductive technology advancements have made gestational surrogacy more widely recognized as a more controlled and predictable process.
The Fertility Clinics segment is expected to have the highest CAGR during the forecast period
In the surrogacy market, the segment with the highest CAGR is fertility clinics. These specialist clinics, which provide a range of cutting-edge reproductive services, are essential in tackling the growing incidence of infertility. Fertility clinics offer thorough diagnostic evaluations, state-of-the-art assisted reproductive technologies (ART), including in vitro fertilization (IVF), and individualized treatment programs made to meet each patient's or couple's specific needs. Additionally, the demand for the services provided by fertility clinics has increased due to rising societal acceptance of ART and increased awareness of fertility issues.
In the global surrogacy market, North America holds the largest share. Because of its sophisticated healthcare system, high level of awareness, and large investments in reproductive technologies, this region-which includes the United States and Canada-dominates. The high demand for fertility services is partly due to the cultural acceptance of assisted reproductive technologies (ART) and the prevalence of infertility problems. Moreover, North America's status as a major player in the reproductive healthcare industry is further cemented by the region's concentration of top fertility clinics, research institutes, and technological developments in the field.
In terms of the global market for surrogacy, the Asia-Pacific region has the highest CAGR. The demand for reproductive services in Asia-Pacific is driven by the rising prevalence of infertility as well as increased understanding and acceptance of assisted reproductive technologies (ART). The region's rapid growth is caused by a number of factors, including evolving lifestyles, postponing family planning, and improvements in reproductive health. Furthermore, expanding fertility treatments and better healthcare infrastructure in Asia-Pacific nations support the market's growth.
Some of the key players in Surrogacy market include Extraordinary Conceptions, Boston IVF, Growing Generations LLC, IVIRMA Global, Max Healthcare, New Hope Fertility Center, Bourn Hall International, Houston Fertility Center, Circle Surrogacy & Egg Donation, Nova Ivi Fertility, Ovation Fertility, Scanfert Clinic and Care Fertility Group.
In November 2023, IVI RMA, one of the largest reproductive medicine groups in the world, has signed a definitive agreement to acquire the North American Operations of Eugin Group, consisting of the Boston IVF fertility network and Toronto-based TRIO, from healthcare group Fresenius. The strategic additions will grow IVI RMA to become a leading fertility group in North America and reinforce the company's commitment to providing evidence-based fertility solutions with the greatest chance of success to the greatest number of patients.
In October 2023, Boston IVF, a renowned leader in fertility research and patient care since its establishment in 1986, is proud to announce its substantial participation in the 2023 American Society for Reproductive Medicine (ASRM) Scientific Congress and Expo. This prestigious annual event, in New Orleans, Louisiana, from October 14-18, brought together global experts to share groundbreaking advancements in technology, treatments, and patient care in reproductive medicine.